Vantrexa · NSCLC · Spain · Oncology pharmacist · captured by Rachel Adeyemi on 25 Jun 2026 · reviewed by Dr. Priya Raman on 26 Jun 2026
Marked as duplicate
Verbatim as captured; never edited
Oncology pharmacist at Hospital Clínic Barcelona raised chemotherapy-free first line during a congress meeting. They noted that colleagues in their network share the view.
Human-approved by Dr. Priya Raman on 26 Jun 2026
Chemotherapy-free first line: practice variation observed reported by oncology pharmacist (ES).
helixor-private-llm-2026.05 · generated 25 Jun 2026, 10:00 UTC
AI summary
Chemotherapy-free first line raised by oncology pharmacist; suggest routing to HEOR.
Source spans used by the model
Oncology pharmacist at Hospital Clínic Barcelona raised chemotherapy-free first line during a congress meeting. They noted that colleagues in their network share the view.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Evidence gap | Evidence gap |
| Function | HEOR | HEOR |
| Priority | High | High |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 4 | 20% | 16.0 |
| Strategic alignment | 2 | 20% | 8.0 |
| Scientific importance | 3 | 15% | 9.0 |
| Urgency | 2 | 15% | 6.0 |
| Novelty | 3 | 10% | 6.0 |
| Actionability | 4 | 10% | 8.0 |
| Confidence | 5 | 5% | 5.0 |
| Breadth of occurrence | 4 | 5% | 4.0 |
| Total | High 62 | ||
| Time | Action | User | Field | Change | Reason | Source |
|---|---|---|---|---|---|---|
| 03 Sept 2026, 14:44 UTC | Create | MTMei Tanaka | dueDate | — → In progress | — | UI |
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
24 Jun 2026 · Dr. Valentina Hayashi, Hospital Clínic Barcelona · MSL Rachel Adeyemi
Insight
Reviewed 26 Jun 2026 by Dr. Priya Raman
Action
Publication project · David Chen · In progress
Decision
Outcome
Closure
Duplicate of INS-0061 — Pharmacists improvising premedication after grade 1 infusion reaction; SmPC not explicit. Supports finishing the 4 outstanding infusion-reaction standard responses.